OX40L-focused CAR-Tregs, designed to target activated APCs, have reduced GVHD lethality by approximately 80% in xenogeneic models by inhibiting Th1 polarisation [416, 418, 419]. This evidence concerns the gene TNFSF4 and graft versus host disease.